$263.33
0.32% yesterday
NYSE, Dec 15, 10:07 pm CET
ISIN
US50540R4092
Symbol
LH

Laboratory Stock price

$263.33
+1.96 0.75% 1M
-0.63 0.24% 6M
+34.01 14.83% YTD
+33.71 14.68% 1Y
+66.35 33.69% 3Y
+86.56 48.97% 5Y
+157.88 149.72% 10Y
+216.57 463.16% 20Y
NYSE, Closing price Mon, Dec 15 2025
-0.85 0.32%

Key metrics

Basic
Market capitalization
$21.9b
Enterprise Value
$27.0b
Net debt
$5.1b
Cash
$598.1m
Shares outstanding
83.0m
Valuation (TTM | estimate)
P/E
25.9 | 15.7
P/S
1.6 | 1.5
EV/Sales
2.0 | 1.9
EV/FCF
19.5
P/B
2.5
Dividends
DPS
$2.88
Yield 1Y | 5Y
1.1% | 0.9%
Growth 1Y | 5Y
0.0% | -
Payout 1Y | 3Y
32.6% | 26.9%
Increased
0 Years
Financials (TTM | estimate)
Revenue
$13.8b | $14.4b
EBITDA
$1.6b | $2.5b
EBIT
$1.4b | $2.1b
Net Income
$855.2m | $1.4b
Free Cash Flow
$1.4b
Growth (TTM | estimate)
Revenue
8.3% | 10.8%
EBITDA
18.9% | 76.9%
EBIT
20.1% | 80.8%
Net Income
96.4% | 87.1%
Free Cash Flow
63.8%
Margin (TTM | estimate)
Gross
28.5%
EBITDA
11.9% | 17.1%
EBIT
9.9%
Net
6.2% | 9.7%
Free Cash Flow
10.0%
Financial Health
Equity Ratio
43.8%
Return on Equity
9.3%
ROCE
8.7%
ROIC
6.4%
Debt/Equity
0.6
More
EPS
$10.2
FCF per Share
$16.6
Short interest
4.9%
Employees
65k
Rev per Employee
$200.0k
Show more

Is Laboratory a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,086 stocks worldwide.

Laboratory Stock Analysis

Unlock Scores for Free

Analyst Opinions

29 Analysts have issued a Laboratory forecast:

23x Buy
79%
6x Hold
21%

Analyst Opinions

29 Analysts have issued a Laboratory forecast:

Buy
79%
Hold
21%

Financial data from Laboratory

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
13,765 13,765
8% 8%
100%
- Direct Costs 9,850 9,850
7% 7%
72%
3,916 3,916
10% 10%
28%
- Selling and Administrative Expenses 2,273 2,273
5% 5%
17%
- Research and Development Expense - -
-
-
1,643 1,643
19% 19%
12%
- Depreciation and Amortization 278 278
13% 13%
2%
EBIT (Operating Income) EBIT 1,365 1,365
20% 20%
10%
Net Profit 855 855
96% 96%
6%

In millions USD.

Don't miss a Thing! We will send you all news about Laboratory directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Laboratory Stock News

Neutral
Business Wire
about 13 hours ago
ST. LOUIS--(BUSINESS WIRE)--Cofactor Genomics, a commercial-stage diagnostics company transforming precision oncology through RNA-based predictive tests, today announced strategic investments from Labcorp and Ascension Ventures. The financing is intended to accelerate Cofactor's nationwide expansion and broaden patient access to its immunotherapy-response diagnostics. Ascension Ventures, the st...
Neutral
Business Wire
13 days ago
FRANKLIN, Tenn. & BURLINGTON, N.C.--(BUSINESS WIRE)--Community Health Systems, Inc. (the “Company”) (NYSE: CYH) announced today that its subsidiary, CHS/Community Health Systems, Inc. (CHS), has completed the sale of select assets of the ambulatory outreach laboratory services of CHS-affiliated health systems in 13 states, including certain patient service centers and in-office phlebotomy locat...
Neutral
PRNewsWire
22 days ago
Bulto, President, U.S. of Novartis, brings global healthcare leadership and growth track record to support Labcorp's long-term strategy BURLINGTON, N.C., Nov. 24, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the appointment of Victor Bulto, a seasoned pharmaceutical executive and member of Novartis' executive leade...
More Laboratory News

Company Profile

Laboratory Corp. of America Holdings is a clinical laboratory company. The firm engages in the provision of clinical laboratory and end-to-end drug development services. It operates through the following segments: LabCorp Diagnostics and Covance Drug Development. The LabCorp Diagnostics segment includes core testing as well as genomic and esoteric testing. The Covance Drug Development segment provides drug development solutions to companies in the pharmaceutical and biotechnology industries. The company was founded in 1971 and is headquartered in Burlington, NC.

Head office United States
CEO Adam Schechter
Employees 65,450
Founded 1971
Website www.labcorp.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today